The scientists you can't reach. The credibility you can't buy. Year round.
BioInsights is a specialist life sciences publisher. Scientists read our journals, attend our webinars and follow our campaigns because the content is independent and accurate. Solution providers work with us to reach that audience.
You bring the data, the case studies and the experts; our science-trained editors and designers turn them into content that sits alongside our editorial. It arrives with the credibility of an independent, peer-reviewed platform. It's shaped by editors who understand it first time. And it stays in front of them all year, as the decision takes shape. That is what gets your solutions in front of the right people, believed, and acted on.
Our Audience
The scientists you need don't respond to LinkedIn, cold email or rented lists. They do read BioInsights. Our audience of decision-makers and hands-on practitioners took a decade to build and can't be bought on any budget. Put your solutions in front of the specific people who need it, whether they sign off the programme or run the process.
Reach biotechs at the start of the R&D process, not after the shortlist is written.
Target by modality and function.
Access decision-makers AND the practitioners who use your technology, not one or the other.
An audience built over ten years, not bought last quarter.
Area of work
Our content formats built around your goals
A content piece on your own website is a sales document, however good the science. The same data, published independently alongside peer-reviewed research, is evidence. BioInsights gives your solutions the standing that makes scientists take it seriously and puts your experts in front of a new field before anyone knows their names
Same data. Independent platform. Different reception.
Turn solution provider claims into evidence scientists will engage with.
Introduce your experts to a new sector where it already reads.
Editorial independence isn't a constraint on your message. It's what makes it believable.
Brand visibility
Put your name in front of decision-makers, across our established digital platforms and audience base
Thought leadership
Position your experts as the trusted voice, through opinion-led content and expert commentary
Sustained engagement
Stay front of mind through multi-touch nurturing and on-demand access
Lead generation
Turn interest into sales-ready contacts, through gated content and registration-driven campaigns.
Content options include:
Our content showcase
View our interactive content showcase to dive into past examples of our work by objective.
View content showcaseWho we work with
.png)
You have the data. We have the people who turn it into something scientists read.
Most solution providers don't lack material. They lack the time and the specialist hands to turn results into content that works.
BioInsights' editors and designers are science-trained: they understand your data, know which formats this audience engages with, and get it right first time. One brief, one partner, from idea to delivery - content that goes to work instead of sitting on your website.
Your data, turned into content - without borrowing your scientists' time.
Formats chosen for what this audience engages with, not what's fashionable.
Fewer review cycles: editors who understand the science first time.
Idea to delivery with one partner, not a chain of agencies.
Our Editors
Abigail Pinchbeck
As a commissioning editor with extensive experience in advanced therapy journal publishing, Abi's focus is on progressing the field by facilitating and disseminating high-impact, open access content covering novel and existing cell and gene therapies.
Abi works closely with academic scientists and industry professionals to publish cutting-edge original research, expert reviews, and multimedia content with a translational and interdisciplinary focus.
Abi's key aim is to explore the latest advances in cell and gene therapy R&D, clinical development, manufacturing, and commercialization.
In addition to Abi’s editorial responsibilities, she maintains a strong network of experts across the biotech and pharma industries, staying up to date with emerging trends and breakthroughs in advanced therapies.
Jokūbas Leikauskas
With a background in science communication and digital publishing, Jokubas focuses on advancing the nucleic acid therapeutics field by commissioning and shaping high-impact, open access content for Nucleic Acid Insights.
As Commissioning Editor, he leads the development of interviews, expert articles, and industry perspectives that highlight emerging advances across mRNA, DNA, oligonucleotide, and drug delivery modalities.
Jokubas is driven to translate complex scientific topics into engaging, accessible content while maintaining strong connections across the nucleic acids community.
Lauren Coyle
As an editor with extensive experience in bioconjugates(i.e., ADCs, conjugate chemistry, diagnostics & imaging, bi/multi-specifics, targeted delivery, and theranostics), Lauren's focus is on advancing the field by facilitating and disseminating high-impact research on conjugation technologies and their applications.
Lauren works closely with researchers, scientists, and industry professionals to publish cutting-edge studies exploring the latest advances in conjugation chemistry, drug delivery systems, and the development and delivery of targeted therapeutics.
In addition to her editorial responsibilities, she maintains a strong network within the biopharma industry, staying up to date with emerging trends and breakthroughs in bioconjugation.
Ashling Cannon
Ashling Cannon works with leading scientists and industry experts to develop high-impact, open-access content across vaccine R&D and manufacturing. She holds a BSc (Hons) in Biological Sciences and an MSc in Wild Animal Biology, with experience in biotechnology and clinical research publishing across journals and books.
Editorial Calendars
Spotlights
Spotlights focus on key topics and emerging technologies, exploring the latest trends, challenges, and breakthroughs in the field. Each Spotlight combines independently peer-reviewed articles, opinion pieces, interviews, webinars, podcasts, short form videos, and more - delivering a comprehensive, accessible, and authoritative update for your target market.
Channel editions
Offer a deep dive into specialized areas of interest for BioInsights members. Each channel provides targeted, high-value content that allows readers to explore the latest developments, challenges, and innovations